New Prospects for Antifungal Chemotherapy
スポンサーリンク
概要
- 論文の詳細を見る
New advances have been made in the serodiagnosis and chemotherapy of fungal diseases and interest in these subjects is currently at peak level. However, the escalating incidence of opportunistic fungal infections, in patients who are debilitated, receiving immunosuppressive therapy, and those who are being treated aggressively for other dis-eases, dictate that improved procedures be developed for the rapid presumptive serologic diagnosis of these diseases along with better antifungal strategies to manage them. This need will continue to increase as a result of the growing number of individuals who are becoming afflicted with the human immunodeficiency virus (AIDS).<BR>Traditional serologic procedures based on detection of antibody are frequently misleading as a result of the changing patterns of disease in the susceptible population and tests that detect antigen have been helpful in identifying some cases, but problems still exist. The technic of DNA hybridization and polymerase chain reaction provide newer approaches worthy of exploitation.<BR>In parallel with the growing incidence of life-threatening fungal infections and efforts to devise tests that rapidly diagnose and monitor them has been the need for and development of new antifungal agents, elucidation of their mechanisms of action, and novel strategies for their delivery. While many improvements have been made there is still problems with toxicity, specificity of action, and efficacy. Research focused on detailing the molecular biology of fungal pathogens provides an alternative strategy for drug development.
- 日本医真菌学会の論文
日本医真菌学会 | 論文
- (1→3)-β-D-グルカン測定の問題点と進歩
- 両側の肺空洞病変にアスペルギルス感染を合併し抗真菌薬, ミカファンギンとイトラコナゾールの併用療法が有効であった Wegener 肉芽腫症の一例
- Trichophyton tonsurans 臨床分離株に対する各種抗真菌薬の in vitro 抗真菌活性
- 爪白癬の治療について : 日本医真菌学会標準化委員会提案2007
- Candida 属菌種のアゾール系薬感受性試験における現行の日本医真菌学会法, およびその改変法とNCCLS M27-A2法との相関性に関する検討